1. Home
  2. RKLB vs BNTX Comparison

RKLB vs BNTX Comparison

Compare RKLB & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rocket Lab USA Inc.

RKLB

Rocket Lab USA Inc.

N/A

Current Price

$53.68

Market Cap

29.6B

Sector

Industrials

ML Signal

N/A

Logo BioNTech SE

BNTX

BioNTech SE

N/A

Current Price

$91.58

Market Cap

24.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RKLB
BNTX
Founded
2006
2008
Country
United States
Germany
Employees
N/A
N/A
Industry
Aerospace
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
29.6B
24.8B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
RKLB
BNTX
Price
$53.68
$91.58
Analyst Decision
Buy
Buy
Analyst Count
14
11
Target Price
$50.38
$137.40
AVG Volume (30 Days)
20.3M
1.4M
Earning Date
11-10-2025
11-03-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$554,535,000.00
$3,698,814,972.00
Revenue This Year
$40.19
$2.36
Revenue Next Year
$48.56
N/A
P/E Ratio
N/A
N/A
Revenue Growth
52.42
3.70
52 Week Low
$14.71
$81.20
52 Week High
$73.97
$129.27

Technical Indicators

Market Signals
Indicator
RKLB
BNTX
Relative Strength Index (RSI) 53.33 32.13
Support Level $52.68 $94.52
Resistance Level $65.18 $97.35
Average True Range (ATR) 4.14 2.33
MACD 1.36 -0.42
Stochastic Oscillator 54.90 2.64

Price Performance

Historical Comparison
RKLB
BNTX

About RKLB Rocket Lab USA Inc.

Rocket Lab Corp is engaged in space, building rockets, and spacecraft. It provides end-to-end mission services that provide frequent and reliable access to space for civil, defense, and commercial markets. It designs and manufactures the Electron and Neutron launch vehicles and Photon satellite platform. Rocket Lab's Electron launch vehicle has delivered multiple satellites to orbit for private and public sector organizations, enabling operations in national security, scientific research, space debris mitigation, Earth observation, climate monitoring, and communications. The business operates in two segments Launch Services and Space Systems. Geographically it serves Japan, Germany, and rest of the world and earns key revenue from the United States.

About BNTX BioNTech SE

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.

Share on Social Networks: